PT Nitrasanata Dharma Tbk (ISX:JECX) EBIT: Rp Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:JECX PT Nitrasanata Dharma Tbk ISX:JECX
10 GF Score
Price Rp1,430.00
! 1 Warning Sign
View Full Analysis

What is PT Nitrasanata Dharma Tbk EBIT?

PT Nitrasanata Dharma Tbk ISX:JECX +5.54% 10 EBIT is Rp Mil as of Dec. 2025. GuruFocus rates ISX:JECX with a GF Score™ of 10/100. The stock has 1 warning sign investors should review.

PT Nitrasanata Dharma Tbk's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2025 was Rp0 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. PT Nitrasanata Dharma Tbk's annualized ROC % for the quarter that ended in Dec. 2025 was 0.00%. PT Nitrasanata Dharma Tbk's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 0.00%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield.

PT Nitrasanata Dharma Tbk  (ISX:JECX) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

PT Nitrasanata Dharma Tbk's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2024 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=0 * ( 1 - % )/( (1167208 + 1441260)/ 2 )
=0/1304234
=0.00 %

where

Invested Capital(Q: Dec. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1422878 - 162669 - ( 270306 - max(0, 304258 - 397259+270306))
=1167208

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1451329 - 180322 - ( 244132 - max(0, 547402 - 377149+244132))
=1441260

Note: The Operating Income data used here is four times the quarterly (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

PT Nitrasanata Dharma Tbk's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2024  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=0/( ( (937420 + max(-142627, 0)) + (981324 + max(-162591, 0)) )/ 2 )
=0/( ( 937420 + 981324 )/ 2 )
=0/959372
=0.00 %

where Working Capital is:

Working Capital(Q: Dec. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(72856 + 28391 + 10855) - (162669 + 0 + 92060)
=-142627

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(70514 + 30339 + 12176) - (180322 + 0 + 95298)
=-162591

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

PT Nitrasanata Dharma Tbk's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=/4877925.889
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Nitrasanata Dharma Tbk EBIT Related Terms

PT Nitrasanata Dharma Tbk EBIT Historical Data

* Premium members only.

The historical data trend for PT Nitrasanata Dharma Tbk's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Nitrasanata Dharma Tbk EBIT Chart

PT Nitrasanata Dharma Tbk Annual Data
Trend Dec23 Dec24 Dec25
EBIT
182,264.00 116,647.00 129,195.00

PT Nitrasanata Dharma Tbk Quarterly Data
Dec23 Dec24 Dec25
EBIT 0.00 0.00 0.00

ISX:JECX vs HCA, THC, DVA: EBIT Comparison

For the Medical Care Facilities subindustry, PT Nitrasanata Dharma Tbk's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PT Nitrasanata Dharma Tbk EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PT Nitrasanata Dharma Tbk's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where PT Nitrasanata Dharma Tbk's EV-to-EBIT falls into.


ISX:JECX
10GF Score
PT Nitrasanata Dharma Tbk ISX:JECX
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Nitrasanata Dharma Tbk EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of Rp Mil mean?
PT Nitrasanata Dharma Tbk (ISX:JECX) has a EBIT of Rp Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on PT Nitrasanata Dharma Tbk.
Is PT Nitrasanata Dharma Tbk's EBIT too high?
PT Nitrasanata Dharma Tbk's current EBIT is Rp Mil. Overall, PT Nitrasanata Dharma Tbk has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does PT Nitrasanata Dharma Tbk's EBIT compare to HCA and THC?
PT Nitrasanata Dharma Tbk's EBIT of Rp Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on PT Nitrasanata Dharma Tbk. PT Nitrasanata Dharma Tbk's current EBIT is Rp Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Nitrasanata Dharma Tbk stock overvalued right now?
PT Nitrasanata Dharma Tbk (ISX:JECX) has a current EBIT of Rp Mil. The current EBIT is Rp Mil. PT Nitrasanata Dharma Tbk's overall GF Score™ is 10/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For PT Nitrasanata Dharma Tbk (ISX:JECX), the current EBIT is Rp Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PT Nitrasanata Dharma Tbk Business Description

Address Jalan Terusan Arjuna Utara No 1, Kedoya West, Kebon Jeruk District, Jakarta, IDN
PT Nitrasanata Dharma Tbk, commercially operating as JEC Eye Hospitals & Clinics, is a specialized healthcare provider focused on eye care services. Its service offerings include Cataract, Laser Vision Correction, Corneal Services, Vitreoretinal Services, Glaucoma Services, etc.
10GF Score

Get the complete analysis for ISX:JECX

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp1,430.00
Price